Our Teams

The selection of the teams is based on the internal program IPE – Institutional Support of Excellence at the Second Faculty of Medicine, Charles University.


Prof. Ondřej Cinek

Molecular Epidemiology of Paediatric Diseases & Microbiology

 

Prof. Ondřej Cinek

Molecular Epidemiology of Paediatric Diseases & Microbiology (IPE 350)

Doc. Petra Laššuthová

Neurogenetic Lab

 

Doc. Petra Laššuthová

Neurogenetic Lab

Use of massively parallel sequencing to elucidate the causes of childhood encephalopathies and early and severe childhood epilepsies, hereditary neuropathies and hereditary spastic parapareses (IPE 441)

Prof. Jakub Hort

Experimentální neurofyziologie a neuropsychologie

 

Prof. Jakub Hort

Experimental neurofyziology and neuropsychology (IPE 442)

Prof. Jan Trka

Childhood Leukaemia Investigation Prague

 

Prof. Jan Trka

Childhood Leukaemia Investigation Prague

Paediatric haematooncology (IPE 462)

Dr Miroslava Hančárová

Lab of Molecular Genetics of Rare Neurodevelopmental Disorders in Children

 

Dr Miroslava Hančárová

Lab of Molecular Genetics of Rare Neurodevelopmental Disorders in Children

Molecular characterisation of the etiology of serious genetic diseases (IPE 716)

Doc. Daniel Smrž

Tumour Immunology

 

Doc. Daniel Smrž

Tumour Immunology

Immune dysregulation in pathological conditions (IPE 722)


The IPE programme serves as institutional support for excellent, especially laboratory biomedical research at the Second Faculty of Medicine of Charles University. The requirement to maintain and increase excellence in research now rightly prevails over the blanket quantitative evaluation of scientific outputs. The faculty considers as excellent outputs especially original scientific publications with a high author share of faculty members in journals with a high impact factor, belonging to the top in their fields (typically in the highest decile or quartile of the field) or patents applied in practice. It appears that there are very limited numbers of excellent research groups at the 2nd Faculty of Medicine, and it is therefore a priority for the faculty to support these groups. The conditions for such support are the demonstrable excellence of published results, the ability to obtain external funding in grant competitions and the building of functional teams with representation of key expertise and age groups at all levels of academic qualifications (PhD students, post-docs and principal investigators).

Was this page useful?